[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100535617":3},{"organization":4,"outcomesModule":7,"designInfo":16,"detailedDescription":11,"studyPopulation":19,"armGroups":11,"interventions":11,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":47,"collaborators":11,"id":49,"slug":11,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":11,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":11,"enrollmentInfo":57,"targetDuration":11,"studyType":60,"phases":11,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":66,"whyStopped":11,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Power Life Sciences Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9,13],{"measure":10,"description":11,"timeFrame":12},"Rate of patients who decide to enroll in a generalized anxiety disorder clinical research.",null,"3 months",{"measure":14,"description":11,"timeFrame":15},"Number of generalized anxiety disorder study participants who remain in clinical study until completion.","12 months",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":17,"timePerspective":18,"maskingInfo":11},"CASE_CROSSOVER","PROSPECTIVE","Individuals with generalized anxiety disorder who are actively contemplating involvement in a clinical trial but have not yet completed the enrollment and randomization process.",[21],{"name":22,"affiliation":5,"role":23},"Michael B Gill","STUDY_DIRECTOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":11,"email":28},"CONTACT","4159004227","bask@withpower.com",[30],{"facility":31,"status":11,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Power Life Sciences","San Francisco","California","94107","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-122.41942,37.77493,{"lat":41,"lon":40},[44],{"name":22,"role":26,"phone":45,"phoneExt":11,"email":46},"415-900-4227","https:\u002F\u002Fwww.withpower.com\u002Fcontact-us@withpower.com",{"type":48,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100535617",false,"NCT06254157","Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials","Generalized Anxiety Disorder Clinical Trials: An Analysis Regarding Engagement Trends and Participation of Generalized Anxiety Disorder Patients Involved in Clinical Trials","Inclusion Criteria:\n\n* Confirmed diagnosis of generalized anxiety disorder\n* Participant must be 18 years of age or older\n* Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.\n\nExclusion Criteria:\n\n* Pregnant or lactating woman\n* Participant is actively receiving study therapy in another\n* Inability to provide written informed consent","ALL","18 Years",{"count":58,"type":59},500,"ESTIMATED","OBSERVATIONAL","Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics.\n\nThis study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial.\n\nAdditionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.",[63],"Generalized Anxiety Disorder",[65],"generalized anxiety disorder","NOT_YET_RECRUITING","2024-02-02",{"date":69,"type":70},"2024-02-12","ACTUAL",{"date":72,"type":59},"2025-03",{"date":74,"type":59},"2027-03",{"name":5,"class":6},1]